Term
| systolic pressure of borderline hypertension |
|
Definition
| 120 to 139 mmHg for greater than 2 weeks |
|
|
Term
| diastolic pressure of borderline hypertension |
|
Definition
| 80 to 89 mmHg for greater than 2 weeks |
|
|
Term
| systolic pressure of Stage 1 hypertension |
|
Definition
| 140 to 159 mmHg for greater than 2 weeks |
|
|
Term
| diastolic pressure of Stage 1 hypertension |
|
Definition
| 90 to 99 mmHg for greater than 2 weeks |
|
|
Term
| systolic pressure of Stage 2 hypertension |
|
Definition
| 160 mmHg or higher for greater than 2 weeks |
|
|
Term
| diastolic pressure of Stage 2 hypertension |
|
Definition
| 100 mmHg or higher for greater than 2 weeks |
|
|
Term
| essential/primary hypertension |
|
Definition
| direct dysfunction of cardiovascular system; cause is generally unknown |
|
|
Term
|
Definition
| condition that affects cardiovascular system |
|
|
Term
| treatment of hypertension |
|
Definition
1) change of lifestyle
2) beta blockers
3) alpha blockers
4) calcium channel blockers
5) diuretics
6) ACE inhibitors |
|
|
Term
| function of beta blockers |
|
Definition
| inhibit beta receptors of cardiac conduction system and cardiac muscle |
|
|
Term
| function of alpha blockers |
|
Definition
| inhibit alpha receptors of vascular smooth muscle |
|
|
Term
| function of calcium channel blockers |
|
Definition
| inhibit calcium channels of cardiac conduction system, cardiac muscle, and smooth muscle |
|
|
Term
|
Definition
| cause excretion of fluids from body |
|
|
Term
| function of ACE inhibitors |
|
Definition
| inhibit production of angiotensin II |
|
|
Term
|
Definition
| decreases heart rate and heart contractility which decreases cardiac output |
|
|
Term
|
Definition
| decreases peripheral resistance which causes vasodilation |
|
|
Term
| effect of calcium channel blockers |
|
Definition
| decreases heart rate, heart contractility, and peripheral resistance |
|
|
Term
|
Definition
|
|
Term
|
Definition
| decrease peripheral resistance and blood volume |
|
|
Term
| treatment of hypotension: pressors that increase blood pressure |
|
Definition
1) epinephrine
2) dopamine
3) phenylephrine
4) vasopressin |
|
|
Term
| epinephrine (description) |
|
Definition
|
|
Term
| effect of β-agonist of epinephrine |
|
Definition
| increase heart rate and heart contractility which increases cardiac output |
|
|
Term
| effect of α-agonist of epinephrine |
|
Definition
| increase peripheral resistance which causes vasoconstriction |
|
|
Term
|
Definition
β-agonist (medium doses)
β-agonist and α-agonist (high doses) |
|
|
Term
| effect of β-agonist of dopamine |
|
Definition
| increases heart rate and contractility which increases cardiac output |
|
|
Term
| effect of β-agonist and α-agonist of dopamine |
|
Definition
| increases heart rate, contractility, and peripheral resistance |
|
|
Term
| phenylephrine (description) |
|
Definition
|
|
Term
| effect of α-agonist of phenylephrine |
|
Definition
| increases peripheral resistance which causes vasoconstriction |
|
|
Term
| vasopressin (description) |
|
Definition
| increases blood volume and α-agonist |
|
|
Term
| effect of α-agonist of vasopressin |
|
Definition
| increases peripheral resistance which causes vasoconstriction |
|
|
